Stem Cell Sciences receives DTI funding

By Melissa Trudinger
Tuesday, 01 February, 2005

A consortium led by Stem Cell Sciences' UK centre has been awarded £1.2 million by the UK Department of Trade and Industry (DTI) to fund a program in drug discovery for regenerative medicine.

The consortium, which comprises Stem Cell Sciences, the Institute for Stem Cell Research at the University of Edinburgh, University College London Biochemical Engineering, GE Biosciences, Global Research Centre and the Insight Faraday Partnership, plans to develop high throughput cell screening using high density arrays of specific cell types derived from embryonic stem cells, which will be used to speed the discovery of drug based regenerative medicines.

The grant was one of three awarded to consortia of academic and industry groups in the bioprocessing sector, a key business area for funding under the DTI's Technology Programme, which aims to speed the translation of collaborative research into successful businesses.

Related News

'Low-risk' antibiotic linked to rise of dangerous superbug

A new study has challenged the long-held belief that rifaximin — commonly prescribed to...

Robotic hand helps cultivate baby corals for reef restoration

The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...

Stem cell experiments conducted in space

Scientists are one step closer to manufacturing stem cells in space — which could speed up...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd